Montana Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• PARTNER 3: 7-Year Follow-Up Shows TAVR and Surgery Comparable in Low-Risk Patients With Symptomatic Severe AS
  TAVR and surgery demonstrated comparable and sustained valve durability in low-risk patients with symptomatic severe aortic stenosis (AS), with both approaches showing low and similar rates of structural valve deterioration (SVD), all-cause bioprosthetic valve failure (BVF) and reintervention through seven years...
• Drinking Sugar-Sweetened Beverages, Fruit Juice May Increase Hypertension Risk
  Sugar-sweetened beverages (SSBs) and fruit juice consumption were positively associated with a higher risk of hypertension independent of diet quality, physical activity and other factors, according to results from the ongoing GUTS study published June 22 in Circulation.
• Do Patients With Reduced LVEF Undergoing LAAO Suffer Worse Outcomes?
  There was no significant difference in procedural success, major in-hospital complications or stroke at one year in patients undergoing transcatheter left atrial appendage occlusion (LAAO) with reduced LVEF; however, these patients did exhibit higher mortality at one year...
• GOAL-HF1: Novel Ghrelin Receptor Agonist Safe, Well-Tolerated Among Patients With HFrEF
  AC01, a novel oral calcium-sensitizing isotope and ghrelin receptor agonist designed to increase myocardial contractility, appeared safe and well-tolerated over a 28-day treatment period in patients with heart failure with reduced ejection fraction (HFrEF), according to results from a phase 1b/2a randomized trial published June 24 in The Lancet.
• ACC Scientific Statement Addresses DOACs in Primary and Secondary Prevention of Thrombotic Events
  Even with robust evidence demonstrating their efficacy and safety, direct oral anticoagulants (DOACs) continue to be underused and, at times, inappropriately dosed, particularly in patients at elevated thrombotic risk.